Days after Glenmark Pharmaceuticals launched its anti-viral drug to treat coronavirus patients, the company's shares surged 40 per cent to Rs 572.7 on Monday in the intra-day trade on the BSE.

Glenmark's shares rise up to 40% following launch of potential coronavirus drug

glenmark-share

Glenmark Share, News on Glenmark Share, stories on Glenmark Share, articles on Glenmark Share, Glenmark Share stories at Wion, Glenmark Share news, Glenmark Share latest news

glenmark share

Glenmark's shares rise up to 40% following launch of potential coronavirus drug